CD274 and Thrombocytopenia: Among all treatment groups, the Chemo + PD-L1 + Anlo regimen had the highest probability of ranking first for PFS (SUCRA = 0.99) and ORR (SUCRA = 0.97), while also exhibiting the highest probability of grade ≥ 3 thrombocytopenia (SUCRA = 0.97) during treatment.